Researchers at Cedars-Sinai Medical Center in Los Angeles found that patients taking GLP-1 agonists before an endoscopy had a 33 percent greater risk of aspiration pneumonia.
GLP-1 medications could raise the risk of complications from GI procedures. The drugs led to a 33 percent greater risk of aspiration pneumonia. READ MORE: Now experts warn ofSurgery patients on blockbuster weight-loss drugs like Ozempic and Wegovy could be at risk of choking to death, a study warns.
Dr Ali Rezaie, study author and medical director of the GI Motility Program at Cedars-Sinai Medical Center in Los Angeles, said: 'Aspiration during or after endoscopy can be devastating.' The drug binds to the GLP-1 receptor, a protein that triggers hormones in the brain that keep the stomach full and tell the body to stop eating and avoid cravings.Ozempic is FDA approved for patients with type 2 diabetes, though off-label use for weight loss has become increasingly common.
Advertisement They found that those who were prescribed GLP-1 medications like Ozempic and Wegovy had a 33 percent higher chance of experiencing aspiration pneumonia than those who didn't take these medications before their endoscopy.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Precautions needed when folks taking Ozempic, Wegovy undergo anesthesiaPatients taking Ozempic or Wegovy should take precautions when undergoing anesthesia. This is because these medications can affect blood sugar levels and may interact with anesthesia drugs. It is important for healthcare providers to be aware of these potential interactions and adjust anesthesia accordingly.
Read more »
Ozempic maker 'very optimistic' after revealing new weight loss pill twice as effective as existing jabsThe maker of the weight loss drugs Ozepmic and WeGovy has revealed a new pill for weight loss that’s twice as effective as its existing jabs.
Read more »
New weight loss pill more effective than Ozempic: Novo NordiskAn experimental new weight loss pill from Danish pharmaceutical giant Novo Nordisk could be twice as effective as its blockbuster Ozempic and Wegovy jabs, early results from a small trial have suggested, sending the firm's shares soaring.
Read more »
Ozempic Gets the Oprah Treatment in a New TV SpecialOprah Winfrey speaks onstage during NAACP Awards in Los Angeles on March 16, 2024.
Read more »
South Korean Senior Doctors to Resign in Support of Ongoing Strike by Junior DoctorsMedical professors queue to submit their resignations during a meeting at Korea University in Seoul, South Korea, Monday, March 25, 2024.
Read more »
Medicare to cover Wegovy when patients also have heart diseaseMedicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, U.S. officials announced Thursday.
Read more »